| human | Q5 |
| P7893 | CIÊNCIAVITAE ID | BC1D-136C-A657 |
| P2798 | Loop ID | 365613 |
| P3835 | Mendeley person ID | esther-julian |
| P496 | ORCID iD | 0000-0002-6558-3978 |
| P3829 | Publons author ID | 2645348 |
| P1053 | ResearcherID | AAI-6610-2020 |
| E-9216-2013 | ||
| P1153 | Scopus author ID | 6701695698 |
| P214 | VIAF ID | 311585006 |
| P735 | given name | Esther | Q837839 |
| Esther | Q837839 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q42656960 | A single point mutation in class III ribonucleotide reductase promoter renders Pseudomonas aeruginosa PAO1 inefficient for anaerobic growth and infection. |
| Q43568167 | An ELISA for five glycolipids from the cell wall of Mycobacterium tuberculosis: Tween 20 interference in the assay. |
| Q41595481 | Antibacterial activity of novel benzopolycyclic amines |
| Q89911436 | Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update |
| Q40468432 | Comparison of antibody responses to a potential combination of specific glycolipids and proteins for test sensitivity improvement in tuberculosis serodiagnosis. |
| Q60639123 | Connaught and Russian Strains Showed the Highest Direct Antitumor Effects of Different Bacillus Calmette-Guérin Substrains |
| Q89660129 | Cording Mycobacterium tuberculosis Bacilli Have a Key Role in the Progression towards Active Tuberculosis, Which is Stopped by Previous Immune Response |
| Q48171098 | Cyclopropanation of α-mycolic acids is not required for cording in Mycobacterium brumae and Mycobacterium fallax. |
| Q42137844 | Demonstration of cord formation by rough Mycobacterium abscessus variants: implications for the clinical microbiology laboratory. |
| Q63374791 | Determinant role for Toll-like receptor signalling in acute mycobacterial infection in the respiratory tract |
| Q38882205 | Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections |
| Q112728659 | Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles |
| Q53968131 | Distribution of surface-exposed antigenic glycolipids in recent clinical isolates of Mycobacterium tuberculosis. |
| Q40695016 | Draft Genome Sequence of Mycobacterium brumae ATCC 51384. |
| Q33457148 | Draft Genome Sequences of Mycobacterium setense Type Strain DSM-45070 and the Nonpathogenic Strain Manresensis, Isolated from the Bank of the Cardener River in Manresa, Catalonia, Spain |
| Q95306560 | Each Mycobacterium Requires a Specific Culture Medium Composition for Triggering an Optimized Immunomodulatory and Antitumoral Effect |
| Q60639155 | Evaluation of a new serodiagnostic tuberculosis test based on immunoglobulin A detection against Kp-90 antigen |
| Q41812952 | Impaired gamma interferon response to Mycobacterium vaccae antigens in patients with cavitary pulmonary tuberculosis. |
| Q47946996 | Increased levels of immunological markers in the respiratory tract but not in serum correlate with active pulmonary mycobacterial infection in mice |
| Q57286500 | Intravesical Mycobacterium brumae triggers both local and systemic immunotherapeutic responses against bladder cancer in mice |
| Q45194396 | Killed but metabolically active Mycobacterium bovis bacillus Calmette-Guérin retains the antitumor ability of live bacillus Calmette-Guérin. |
| Q53111131 | Magneto-actuated immunoassay for the detection of Mycobacterium fortuitum in hemodialysis water. |
| Q28544447 | Methyl-hydroxylamine as an efficacious antibacterial agent that targets the ribonucleotide reductase enzyme |
| Q42706987 | Misdiagnosis of Mycobacterium brumae infection |
| Q47757321 | Molecule confirmation and structure characterization of pentatriacontatrienyl mycolate in Mycobacterium smegmatis |
| Q36167179 | Mycobacteria Clumping Increase Their Capacity to Damage Macrophages |
| Q27346705 | Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment |
| Q97414226 | Mycobacteria-Based Vaccines as Immunotherapy for Non-urological Cancers |
| Q94449745 | Mycolicibacterium brumae Is a Safe and Non-Toxic Immunomodulatory Agent for Cancer Treatment |
| Q46942763 | Neutral-red reaction is related to virulence and cell wall methyl-branched lipids in Mycobacterium tuberculosis. |
| Q38672153 | Nonpathogenic Mycobacterium brumae Inhibits Bladder Cancer Growth In Vitro, Ex Vivo, and In Vivo. |
| Q74064239 | Occurrence of an antigenic triacyl trehalose in clinical isolates and reference strains of Mycobacterium tuberculosis |
| Q58617487 | Pentafluorosulfanyl-containing Triclocarban Analogs with Potent Antimicrobial Activity |
| Q39942356 | Prevalence and concentration of non-tuberculous mycobacteria in cooling towers by means of quantitative PCR: a prospective study |
| Q60639152 | Production of Antibodies against Glycolipids from the Mycobacterium tuberculosis Cell Wall in Aerosol Murine Models of Tuberculosis |
| Q44553483 | Revisited mycolic acid pattern of Mycobacterium confluentis using thin-layer chromatography. |
| Q42094561 | Surface spreading motility shown by a group of phylogenetically related, rapidly growing pigmented mycobacteria suggests that motility is a common property of mycobacterial species but is restricted to smooth colonies. |
| Q28237723 | The production of a new extracellular putative long-chain saturated polyester by smooth variants of Mycobacterium vaccae interferes with Th1-cytokine production |
| Q52558845 | Therapeutic efficacy of the live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in a preclinical model of bladder cancer. |
| Q41108337 | Trehalose Polyphleates, External Cell Wall Lipids in Mycobacterium abscessus, Are Associated with the Formation of Clumps with Cording Morphology, Which Have Been Associated with Virulence. |
| Q41112688 | γ Irradiated Mycobacteria Enhance Survival in Bladder Tumor Bearing Mice Although Less Efficaciously than Live Mycobacteria. |
Search more.